Harmony Biosciences
HRMY
HRMY
182 hedge funds and large institutions have $2.29B invested in Harmony Biosciences in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 72 increasing their positions, 62 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
4% more capital invested
Capital invested by funds: $2.21B → $2.29B (+$85.8M)
1% more funds holding
Funds holding: 181 → 182 (+1)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
Holders
182
Holding in Top 10
7
Calls
$3.6M
Puts
$292K
Top Buyers
| 1 | +$28.1M | |
| 2 | +$25.8M | |
| 3 | +$20.1M | |
| 4 |
NPIC
Neumeier Poma Investment Counsel
Carmel,
California
|
+$18.8M |
| 5 |
LCG
Lisanti Capital Growth
New York
|
+$14.8M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$23.2M | |
| 3 | -$16.7M | |
| 4 |
Two Sigma Investments
New York
|
-$9.41M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$8.77M |